Janux Therapeutics Inc — 財務諸表 (NASDAQ:JANX) | MetaTrader

チャート全体を表示

ニュース

Truist、競合激化でJanux Therapeuticsの目標株価を引き下げ

Truist cuts Janux Therapeutics stock price target on competition

Janux therapeutics doses first participant in JANX011 phase 1 trial

Vir Biotechnology Stock: The Low-Down On The Readouts Ahead (NASDAQ:VIR)

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

Januxセラピューティクス、ウィリアム・ゴーを新チーフメディカルオフィサーに任命

Janux Therapeutics appoints William Go as new chief medical officer

Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion (BMY)

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

ブリストル・マイヤーズスクイブとの提携契約でジャナックス株が上昇

Janux stock rises after Bristol Myers Squibb collaboration deal

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million - Janux Therapeutics (NASDAQ:JANX)